1 – 22 of 22
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B : post hoc analysis of phase III trials using patient-reported outcomes
(
- Contribution to journal › Article
-
Mark
High use of pain, depression, and anxiety drugs in hemophilia : more than 3000 people with hemophilia in an 11-year Nordic registry study
(
- Contribution to journal › Article
- 2017
-
Mark
Comparative burden of arthropathy in mild haemophilia : a register-based study in Sweden
(
- Contribution to journal › Article
- 2016
-
Mark
Aspects of prophylactic treatment of hemophilia
(
- Contribution to journal › Scientific review
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
(
- Contribution to journal › Article
- 2014
-
Mark
Textbook of hemophilia : Care of the child with hemophilia
2014) p.145-150(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
- 2006
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article
- 2000
-
Mark
Treatment of children with haemophilia in Europe: A survey of 20 centres in 16 countries
(
- Contribution to journal › Article
- 1999
-
Mark
Prenatal diagnosis of haemophilia
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Can haemophilic arthropathy be prevented?
(
- Contribution to journal › Special issue (editor)
- 1997
-
Mark
Identifying carriers at high risk for negative reactions when performing prenatal diagnosis of haemophilia
(
- Contribution to journal › Article
-
Mark
Factor IX inhibitors and anaphylaxis in hemophilia B
(
- Contribution to journal › Article
- 1995
-
Mark
Gene mutations and inhibitor formation in patients with hemophilia B
(
- Contribution to journal › Article
- 1990
-
Mark
Two factor IX mutations in the family of an isolated haemophilia B patient : direct carrier diagnosis by amplification mismatch detection (AMD)
(
- Contribution to journal › Article
- 1989
-
Mark
How do carriers of hemophilia experience prenatal diagnosis (PND)? : Carriers' Immediate and later reactions to amniocentesis and fetal blood sampling
(
- Contribution to journal › Article
- 1987
-
Mark
How do carriers of hemophilia experience prenatal diagnosis by fetal blood sampling?
(
- Contribution to journal › Article
- 1983
-
Mark
Detection of factor IX inhibitors by immunoradiometric assay
(
- Contribution to journal › Article
- 1982
-
Mark
Genetic variants of haemophilia B detected by immunoradiometric assay : implications for prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Haemophilia A and B--two years experience of genetic counselling and prenatal diagnosis
(
- Contribution to journal › Article
- 1980
-
Mark
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX
(
- Contribution to journal › Article